CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the UBS Global Life Sciences Conference on Monday, September 19, 2011 at 3:30 p.m. ET at the Grand Hyatt New York.
